BackgroundGender affirming hormone therapy (GAHT). whilst considered the standard of care in clinical guidelines for the treatment of many transgender (trans) people is supported by low quality evidence. In this prospective longitudinal controlled study. we aimed to examine the effect of newly commencing GAHT on gender dysphoria and quality of life (QoL) over a 6 month period. https://www.chiggate.com/replica-beach-walk-candle-fashion/